Feed Insights Top Reports Pricing

⌘K

16:15:00·1414d

PRReleasevia Quantisnow

MBIA Inc. Reports Second Quarter 2022 Financial Results

ByQuantisnow·Wall Street's wire, on your screen.

MBI· MBIA Inc.

Finance

Plus alert sent

Quantisnow Plus members were alerted at 16:15:04 ET - 4.1s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment MBI files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MBI (MBIA Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

SEC Form 11-K filed by MBIA Inc.
Director Vaughan Richard C was granted 16,181 shares, increasing direct ownership by 19% to 103,055 units (SEC Form 4)
Director Shasta Theodore was granted 16,181 shares, increasing direct ownership by 32% to 66,327 units (SEC Form 4)
Director Innis-Thompson Janice L. was granted 16,181 shares, increasing direct ownership by 24% to 83,325 units (SEC Form 4)
Director Gilbert Steven J was granted 16,181 shares, increasing direct ownership by 15% to 125,423 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022